Cost-Effectiveness of Blood-Based Biomarkers for Colorectal Cancer Screening—An Ounce of Prevention Is Worth a Pound of Cure
JAMA Network Open · 16.11.2023 · 6 (11) · e2343346
DOI: 10.1001/jamanetworkopen.2023.43346 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Network Open, online erschienen am 16.11.2023. Verfasst von John M Inadomi. Beteiligte Einrichtung: Department of Internal Medicine, The Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City. Hauptthemen laut MEDLINE: Early Detection of Cancer, Colorectal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Zainab Aziz, BS; Sophie Wagner, BS; Alice Agyekum, BS; Yoanna S. Pumpalova, MD; Matthew Prest, MS; Francesca Lim, MS; Sheila Rustgi, MD; Fay Kastrinos, MD, MPH; William M. Grady, MD; Chin Hur, MD, MPH
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, The Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City.
Zitieren
APA
Inadomi, J. M. (2023). Cost-Effectiveness of Blood-Based Biomarkers for Colorectal Cancer Screening—An Ounce of Prevention Is Worth a Pound of Cure. JAMA Network Open, 6(11), e2343346. https://doi.org/10.1001/jamanetworkopen.2023.43346
Vancouver
Inadomi JM. Cost-Effectiveness of Blood-Based Biomarkers for Colorectal Cancer Screening—An Ounce of Prevention Is Worth a Pound of Cure. JAMA Network Open. 2023;6(11):e2343346. doi:10.1001/jamanetworkopen.2023.43346
BibTeX
@article{Inadomi2023,
author = {Inadomi, John M},
title = {Cost-Effectiveness of Blood-Based Biomarkers for Colorectal Cancer Screening—An Ounce of Prevention Is Worth a Pound of Cure},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {11},
pages = {e2343346},
doi = {10.1001/jamanetworkopen.2023.43346}
}
EUVIMED